Stocks
AnaptysBio (ANAB) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 12 340% | 14 064% | 7 211% | 24 804% | 16 392% | 41 189% | |||
| Changes by years, y/y, % | +7 054pp | +1 724pp | -6 854pp | +17 593pp | -8 412pp | +25.4% | |||
AnaptysBio. R&D/CAPEX, %
AnaptysBio. R&D/CAPEX, changes, pp
AnaptysBio (ANAB) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 19 060% | 11 973% | 136 589% | 126 797% | 120 606% | 41 189% | ||
| Changes by years, y/y, % | -25 068pp | -1 383pp | +116 613pp | +109 469pp | +101 545pp | |||
| Changes by quarters, q/q, % | +1 733pp | -7 087pp | +124 616pp | -9 792pp | -6 191pp | |||
